Search
Search Results
##search.searchResults.foundPlural##
-
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1309PDF: 505HTML: 207 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2409PDF: 1011HTML: 1654Fig 1: 190Tab I: 219Cover Letter: 211 -
Pseudo-differentiation syndrome
1386PDF: 672HTML: 10852Figure 1: peripheral blood showing myeloblasts with auer rods: 120Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 105Figure 3: CXR showing pulmonary infiltartes with consolidation: 137Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 118Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 119 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2157PDF: 1011HTML: 4079Cover Letter: 226Figure 1: 238Figure 2: 235Table 1: 208 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4433PDF: 1730HTML: 1055 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
755PDF: 881PDF Supp. Files: 79HTML: 193 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2049PDF: 774HTML: 3118 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1606PDF: 627HTML: 233 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1423PDF: 829HTML: 8664Fig 3 Savini: 179Fig 2 Savini: 186Fig 1 Savini Chest TC: 192Author letter to referees: 191 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1248PDF: 606HTML: 2870ATRA induced Reactive Hemophagocytosis: A Case Report: 203 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4845PDF: 1798HTML: 2724Untitled: 227 -
-
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
997PDF: 542HTML: 729 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4851PDF: 1826HTML: 2165 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1278PDF: 1018HTML: 226 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4097PDF: 1164HTML: 1996Fig.1: 219Fig. 2: 113Table 1: 207Table2: 225Table 3: 204 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4118PDF: 1265HTML: 1963Table 1: 204 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1590PDF: 1046HTML: 238 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1324PDF: 1023HTML: 126 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
896PDF: 502HTML: 161Suppl. Files: 331 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1307PDF: 1514Suppl. Files: 150HTML: 82







